Pharma Resisting Efforts To Send Drug Pricing Savings To US Budget ‘Black Hole’ – Pfizer’s Bourla

 
• By Cathy Kelly
  
Drug Savings Should Enhance Access, Not Get Lost In Other Spending Priorities, Firms Say

More from Pricing Debate

More from Market Access